The prevalence and molecular characteristics of penicillinase-producing Nei
sseria gonorrhoeae (PPNG) and tetracycline-resistant N. gonorrhoeae (TRNG)
were determined in 10 clinics in Monrovia, Liberia, to assess the likely ef
fectiveness of the current standard treatment with penicillin or tetracycli
ne. One hundred gonococcal strains were isolated from 146 urethral swabs an
d 261 cervical swabs and screened for susceptibility to ceftriaxone, penici
llin, spectinomycin and tetracycline by the disk diffusion method; 83% were
resistant to penicillin and 63% to tetracycline. Twenty-one strains from 1
8 men and 3 women with uncomplicated gonorrhoea were subjected to more deta
iled characterization. These 21 strains belonged to 5 auxotype/serovar clas
ses; 86% were PPNG/TRNG. Three PPNG harboured the 4.4 MDa penicillinase pla
smid and 16 the 3.2 MDa plasmid. All TRNG harboured the 25.2 MDa plasmid an
d their MICs for tetracycline were >32 mg/L. They gave a PCR product which,
according to its restriction pattern, corresponded to the American type te
tM gene. By the agar dilution method, all strains exhibited intermediate re
sistance to sulphamethoxazole-trimethoprim (19:1) (co-trimoxazole) with MIC
s of 8-32 mg/L. Al strains were susceptible to spectinomycin and ciprofloxa
cin. The MICs for gentamicin were 4-8 mg/L. The use of effective and afford
able antimicrobial chemotherapy with either 500 mg ciprofloxacin or a singl
e dose of gentamicin is discussed, with consideration of molecular biologic
al, pharmacological and public health aspects.